Preclinical Efficacy for AKT Targeting in Clear Cell Carcinoma of the Ovary

The aim of this study was to determine the role of AKT as a therapeutic target in ovarian clear cell carcinoma (CCC), an aggressive, chemoresistant histological subtype of ovarian cancer. AKT activation was assessed by immunohistochemistry (IHC) using human tissue microarrays of primary ovarian canc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Cancer Res
Main Authors: Sasano, Tomoyuki, Mabuchi, Seiji, Kuroda, Hiromasa, Kawano, Mahiru, Matsumoto, Yuri, Takahashi, Ryoko, Hisamatsu, Takeshi, Sawada, Kenjiro, Hashimoto, Kae, Isobe, Aki, Testa, Joseph R., Kimura, Tadashi
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4398602/
https://ncbi.nlm.nih.gov/pubmed/25519148
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1541-7786.MCR-14-0314
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados